Edap TMS SA (EDAP)
5.32
-0.06
(-1.12%)
USD |
NASDAQ |
Jun 17, 14:52
Edap TMS Total Long Term Debt (Quarterly): 4.687M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.687M |
December 31, 2023 | 6.650M |
September 30, 2023 | 4.282M |
June 30, 2023 | 4.759M |
March 31, 2023 | 4.952M |
December 31, 2022 | 7.543M |
September 30, 2022 | 5.168M |
June 30, 2022 | 6.577M |
March 31, 2022 | 6.484M |
December 31, 2021 | 8.689M |
September 30, 2021 | 7.690M |
June 30, 2021 | 7.928M |
March 31, 2021 | 2.987M |
December 31, 2020 | 10.22M |
September 30, 2020 | 3.144M |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 5.525M |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 6.306M |
September 30, 2018 | 0.00 |
June 30, 2018 | 4.054M |
March 31, 2018 | 0.00 |
Date | Value |
---|---|
December 31, 2017 | 4.721M |
September 30, 2017 | 0.00 |
June 30, 2017 | 1.986M |
March 31, 2017 | 0.00 |
December 31, 2016 | 2.355M |
September 30, 2016 | 0.00 |
June 30, 2016 | 2.011M |
March 31, 2016 | 0.00 |
December 31, 2015 | 3.952M |
September 30, 2015 | 0.00 |
June 30, 2015 | 3.798M |
March 31, 2015 | 0.00 |
December 31, 2014 | 3.142M |
September 30, 2014 | 0.00 |
June 30, 2014 | 3.412M |
March 31, 2014 | 0.00 |
December 31, 2013 | 3.503M |
September 30, 2013 | 0.00 |
June 30, 2013 | 2.627M |
March 31, 2013 | 0.00 |
December 31, 2012 | 9.433M |
September 30, 2012 | 0.00 |
June 30, 2012 | 3.284M |
March 31, 2012 | 0.00 |
December 31, 2011 | 12.62M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
10.22M
Maximum
Dec 2020
4.864M
Average
5.060M
Median
Total Long Term Debt (Quarterly) Benchmarks
Cellectis SA | 45.22M |
DBV Technologies SA | -- |
Genfit SA | 71.07M |
Biodexa Pharmaceuticals Plc | 0.00 |
NuCana PLC | -- |